Abstract
A study published in this issue of Heart explores the associations between plasma osteoprotegerin (OPG) collected within 48 h of the onset of symptoms of a non-ST elevation acute coronary syndrome (NSTE-ACS) and 30 day and 1 year incidence of cardiovascular death.1 A strong association was observed between OPG and cardiovascular mortality, and baseline OPG was also an independent predictor of new or worsening heart failure (HF).
Lingua originale | English |
---|---|
pagine (da-a) | 762-763 |
Numero di pagine | 2 |
Rivista | Heart (British Cardiac Society) |
Volume | 98 |
DOI | |
Stato di pubblicazione | Pubblicato - 2012 |
Keywords
- Acetanilides
- Acute Coronary Syndrome
- Electrocardiography
- Female
- Humans
- Male
- Osteoprotegerin
- Piperazines